Late-Phase Clinical Trials
Optimal Clinical Trials is a leading New Zealand-based patient recruitment site, specialising in late-phase clinical trials across more than 20 therapeutic areas.
In 2025, Optimal delivered late-phase clinical trials at speed and scale across vaccines, metabolic, dermatology and many other therapeutic areas.
Key results include:
- Delivered the first global participant within 24 to 48 hours of activation for two eczema studies, a prurigo nodularis study, and a coeliac study
- Delivered first participant in Asia-Pacific for a Covid-19 study
- Delivered first participant in Australia and New Zealand for a vitiligo study
- Delivered first New Zealand participants for a flu vaccine study, two obesity studies, a vitiligo study, and a coeliac study
- Delivered the first global randomised participant for a coeliac study, a prurigo nodularis study, and a vitiligo study
- Multiple monthly highest recruitment recognitions for eczema, alopecia, vitiligo, asthma, and gout studies
- Highest global enrolment at completion for an eczema, a menopause, and a flu vaccine study, as well as the highest participant retention in New Zealand for a gout study
Learn more at https://www.optimalclinicaltrials.com/client-hub/pharmaceutical-biotech-and-cros
